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Abstract 
Introduction: Lateral internal sphincterotomy (LIS) is still the approach of choice for the treatment of chronic anal 
fissure (CAF) regardless to the internal anal sphincter tone but it is burdened by high risk post-operative faecal incon-
tinence (FI). In female patient there are some anatomical and functional differences of the sphinteric system which 
make them more at risk of FI and vaginal birth could cause sphinteric lesions affecting the anal continence function. 
The aim of our study is to evaluate the results of saving sphincter procedure as treatment for female patients affected 
by CAF.
Methods: We studied 110 female patients affected by CAF undergone fissurectomy and anoplasty with V–Y cutane-
ous flap advancement associating pharmacological sphincterotomy in patients with hypertonic IAS. The follow up 
was at least for 2 years. The goals were patient’s complete healing, the evaluation of FI, recurrence rate and manom-
etry parameters.
Results: All wounds healed within 40 days after surgery. We recorded 8 cases of recurrences 6 healed with medical 
therapy and 2 with dilatation. We recorded 2 “de novo” temporary and low grade post-operative cases of FI. Post-oper-
ative value of MRP were unmodified in patient with normotonic IAS but significantly lower at 12 months follow up as 
compared with the pre-operative ones in patients with hypertonic IAS; after 24 months from surgery MRP values were 
within the normal range.
Conclusion: The fissurectomy and anoplasty with V–Y cutaneous flap alone or in association with a pharmacologi-
cal sphincterotomy in patients with hypertonic IAS may represent an effective approach for the treatment of CAF in 
female patients.
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Introduction
Chronic anal fissure (CAF) is a frequently occurring 
proctology lesion, which presents itself as a painful 
superficial tear in the cutaneous- mucosal transition zone 
of the anal canal. First line therapy is medical treatment 
with a dietary-higenyc and pharmacological approach. 
Nevertheless, in the event of CAFs, which are refractory 
to dietary and pharmacological therapy, lateral internal 
sphincterotomy (LIS) is still suitable as the treatment 
of choice independently from IAS tone. In fact, this lat-
ter surgical procedure is characterised by a low rate of 
post-operative complications and a high healing rate. The 
greatest disadvantage of this latter procedure is repre-
sented by the high rate of faecal incontinence occurrence 
(FI), which accounts for up to 30–40%. A meta-analysis 
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from 2013, which evaluated long-term incidence of FI 
after LIS, showed an overall continence alteration risk 
of 14% [1]; however, on severity analysis, flatus inconti-
nence and soilage/seepage were much commoner than 
frank incontinence to liquid or solid stool [2]. FI has a 
strong impact on the quality of life of patients and it can 
be more disabling than CAF itself; actually, patients tend 
to better bear a recurrence than FI [3]. From the guide-
lines for CAF treatment from different countries [4–9] 
we understand that the risk factors for FI occurrence are 
female gender, old age and the absence of an hypertonic 
IAS. In female patient there are some anatomical and 
functional [10] of the sphinteric system as compared to 
male patients, which make them more at risk of FI after 
proctological procedures; moreover, with vaginal birth 
sphinteric lesions may occur, which could affect the anal 
continence function. To reduce the risk of post-operative 
FI, the mostly used surgical procedure is fissurectomy 
alone or in association with pharmacological sphincter-
otomy and/or cutaneous or mucosal flap advancement.
The aim of our study is to evaluate the results of fis-
surectomy and anoplasty with V–Y cutaneous flap 
advancement in female patients affected by CAF.
Materials and methods
This retrospective study involves 110 consecutive female 
patients, all affected by idiopathic and non-recurrent 
CAF who underwent surgical procedure, from January 
2010 to January 2019. Exclusion criteria for the study 
were: the presence of multiple fissures, fistulas in ano, 
syphilis, inflammatory bowel disease, anal abscess, malig-
nant disease and previous anorectal surgery. All patients 
were followed up for at least 2  years after the surgical 
procedure. The patients’ outcome data were retrieved 
from a prospectively monitored database.
We conduct this study in compliance with the princi-
ples of declaration of Helsinki, the protocol for this study 
has been submitted to the Ethical Committee of our 
institution, which did not consider necessary to approve 
it. Written informed consent was obtained from all the 
study participants.
Preoperative manometric evaluation was performed 
after a reasonable period of suspension of all medical 
therapy influencing IAS tone. The manometric evalua-
tion was carried out by a manometric sensor using the 
station pull-through as described in our previous work 
[11]. A manometric evaluation has been undertaken at 12 
and 24 months after surgery.
Data collected on healthy subjects by our anorec-
tal pathophysiological laboratory showed that nor-
mal values of maximum resting pressure (MRP) and 
maximum squeeze pressure (MSP) were respectively 
68.1 ± 12.3  mmHg and 112 ± 36.2  mmHg [11]. The 
normal range of MRP, according to Jones et al. [12], were 
45–85 mmHg; so that CAF without hypertonic IAS were 
defined as those with MRP values < 85 mmHg.
All patients underwent fissurectomy and anoplasty 
with V–Y skin flap advancement lying in a gynecological 
position under spinal or general anesthesia.
The sentinel skin tags and hypertrophied anal papilla 
located at the dentate line were excised, if present; the 
tissue at the base of the fissure was curetted until clean 
IAS muscle fibers were reached. Technical details con-
cerning the surgical procedure have already been widely 
explained in a previous work from our group [13].
The patients with hypertonic IAS were treated with 
intraoperative local injection of 30 U.I. of botulinum 
toxin A (Botox, Allergan Westport, Ireland) [14] or with 
local administration of post-operative nifedipine and 
lidocaine for 15  days after surgery (Antrolin ®) [15]. 
Before surgery, all patients received a small volume of 
phosphate-saline enema. Metronidazole was adminis-
tered intravenously in a dose of 500 mg 1 h before sur-
gery, subsequently, it was administered per os at the 
dosage of 250 mg for 7 days, three times daily. During the 
first two weeks after the surgery, patients took variable 
doses of psyllium fibers. A laxative preparation (senno-
sides) was given orally to subjects who had not yet passed 
stools 3 days after surgery. Immediately after surgery, all 
patients received 100  mg of diclofenac intramuscularly 
for analgesia and were instructed to take only 100 mg of 
nimesulide tablets as requires.
A complete healing was defined as a complete epi-
thelialization of the advancement skin flap. Recurrent 
CAFs were defined as those who occurred after the com-
plete healing of the previous wound. Both duration and 
intensity of post-defecatory pain have been evaluated; 
the intensity was evaluated with a visual analogue scale 
(VAS).
FI was assessed preoperatively and 6, 12 and 24 months 
after surgery according to Pescatori’s grading system 
[16]: A incontinence for flatus and mucus; B for liquid 
stool; C for solid stool; 1 for occasional; 2 for weekly and 
3 for daily. Patients were discharged within 24  h after 
surgery, afterwards they were examined until they were 
completely healed with a first appointment after 3  days 
from surgery, a second on post-operative day 10 and on 
a regular basis each 10 days for the first two months after 
surgery. They were also followed up until 24 months fol-
lowing the surgical procedure. Independently of the 
scheduled appointments, patients have been seen on 
request.
Statistical analysis
Data were analyzed by standard statistical methods and 
the results were expressed as means ± standard deviation. 
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Differences between continuous data were compared 
using Student t test for paired and unpaired samples, 
whereas differences between percentages were analyzed 
using Fisher test. Probability values of < 0.05 were consid-
ered significant.
Results
Demographic, clinical characteristics of CAF of the 
patients object to study are reported in Table  1. We 
observed an anterior location of the CAF in the 34.5% 
of patients, while we recorded an hypertonic IAS in the 
65.5% of them (Table  2). Among the 72 patients with 
hypertonic IAS, we treated 40 of them with the injec-
tion of Botulinum Toxin A, while 32 of them with topical 
administration of nifedipine and lidocaine ointment. At 
40 days after the surgical procedure we achieved a com-
plete wound healing a resolution of clinical symptoms. 
The duration and intensity of post-defecatory pain have 
significantly reduced as compared with the pre-operative 
values since the first defecation (Table 3).
Manometry findings
At 12 and 24 months after surgery MRP and MSP values 
were substantially unmodified in the patients with nor-
motonic IAS (Table 4). In those patients with hypertonic 
IAS MSP values were immodified as compared to the 
values at 12 and 24 months after surgery; whereas MRP 
ones were significantly lower at 12  months follow-up 
as compared to the pre-operative ones but still signifi-
cantly higher than those measured in healthy controls. 
At 24  months follow up after surgery MRP values were 
within normal range (Table 5).
Faecal incontinence
We recorded 15 cases of pre-operative FI (13.63%), in 
7 of them CAF was located at the anterior commissure 
(18.42%), in 8 of them at the posterior one (11.11%). FI 
cases and rate recorded pre-operatively related to child-
births are reported in Tables 6 and 7 and those related to 
the location in Table 8.
According to Pescatori’s grading system [17] 10 were 
classified as A1, 4 as A2 and 1 as A3. We observed only 
2 “de novo” case of post-operative FI both classified as 
Table 1 Clinical and demographic characteristics of CAF
No. %
Gender
 Female 110 100
Age (mean ± standard deviation) 36.5 ± 15.8
Hypertrophied anal papilla 88 80.0
Skin tags 82 74.6
Symptoms
  Pain 110 100
  Bleeding 88 80.0
  Pruritus 66 60.0
Duration of symptoms
  Months (mean ± standard deviation) 12.1 ± 7.3
Table 2 Location and IAS tone in the patients object to study
Location Normotonic IAS Hypertonic IAS Total
N° % N° % N° %
Anterior 21 55.3 17 44.7 38 34.5
Posterior 17 23.6 55 76.4 72 65.5
Total 38 34.5 72 65.5 110 100
Table 3 Intensity of pain evaluated by VAS and duration of pain 
expressed in minutes after defecation
Values are expressed as mean and standard deviation. Student’s t test with 
Welch correction was used to compare the difference between each point. 
Significance. 1st defecation vs preoperative *p < 0.01
Intensity of pain Duration of pain
Preoperative 8.5 (1.3) 165 (40.3)
1st defecation 4.2 (1.5)* 100 (35.1)*
3rd defecation 4.1 (1.1) 60.5 (20.8)
5th defecation 3.0 (0.6) 30.2 (12.3)
7th defecation 2.2 (0.7) 10.4 (5.1)
9th defecation 0.8 (0.3) 5.1 (2.8)
10th defecation 0.2 (0.4) 2.8 (0.7)
Table 4 MRP and MSP values as mean ± standard deviation 
in patients with normotonic CAF before and after the surgical 
procedure
MRP (mmHg) MSP (mmHg) p
Healthy subjects 68.1±12.3 112±36.2 n.s.
Pre-operative 59.3±15.1 107±26.4
12 months after surgery 63.5±18.6 110±22.3
24 months after surgery 61.3±12.1 103±17.1
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A1 and temporaries. We recorded a temporary wors-
ening of A1 pre-operative grading in 2 cases: in the 
first one it occurred in patients treated with Botu-
linum Toxin A injection and the CAF was located at 
the posterior commissure; in the other one the IAS 
tone was normal and the CAF located at the anterior 
commissure.
Recurrence
At 24 months after the surgical procedure follow-up we 
recorded 8 recurrences (7.3%). In 6 of them MRP values 
were normal and they were successfully treated with con-
servative therapy (pharmacological and hygienic-dietary 
approach). In 2 cases there was a mild hypertonic IAS, 
these latter have been treated with dilatation with com-
plete healing.
Complications and follow‑up
We did not observe any anal stenosis nor keyhole deform-
ity. At the same time, we did not record any necrosis of 
the transposed flap. The post-operative complications 
we were able to observe were of slight entity and they 
didn’t require, in any case, further surgical procedures; in 
particular we observed 1 case of infection located at the 
donor site as well as 8 case of partial break down.
Discussion
The results of this study show that fissurectomy and ano-
plasty associated with a pharmacological therapy in case 
of hypertonic IAS is feasible and effective; this procedure 
allows a perfect post-operatory faecal continence and a 
low rate of recurrence.
LIS is the treatment of choice for CAFs, but in female 
patient both of childbearing age or elderly it is not appro-
priate to undertake this procedure, nor in the traditional 
nor in the new proposed variant [17–23]; due to the high 
risk of immediate or long term post-operative FI, caused 
by some anatomical, clinical and functional features typi-
cal of these patients as compared to male ones, which 
expose female patients to a higher risk of FI [24].
Murad-Regadas et  al. [25], through a 3-D anal endo-
sonography have demonstrated an asymmetrical con-
figuration of anal canal and a difference between the two 
genders. In women patients both external anal sphincter 
(EAS) and IAS are shorter at the anterior level and they 
are characterized by a longer gap, which may justify 
the higher incidence of pelvic disfunction. It is still not 
known whether some women have slightly different pres-
sure distribution in the distal anal canal predisposing to 
a higher risk than man for the development of anterior 
CAF [26]. Ellis [27] reported that patients affected by 
anterior CAF are frequently affected also by rectocele at 
physical examination with a typical manometric profile 
(high pressure zone shortened with low to normal resting 
pressure).
We shall consider that female patients of childbearing 
age could give birth by vaginal delivery during which the 
lesions of the anal sphincteric system may occur. Sultan 
et al. [28], report in their study that an isolated disfunc-
tion of the IAS might occur after vaginal delivery in the 
Table 5 MRP and MSP values as mean ± standard deviation in 
patients with hypertonic CAF vs healthy subjects before and after 
the surgical procedure
MRP (mmHg) p MSP (mmHg) p
Healthy subjects 69.8 ± 11.8 112 ± 36.2
Patients with CAF
 Pre-operative 95.3 ± 8.5 0.0001 109.2 ± 46.5 n.s.
 12 months after surgery 77.3 ± 15.2 0.0018 115.1 ± 28.9
 24 months after surgery 70.2 ± 10.5 n.s. 107.9 ± 31.9




N° % N° %
Nulliparous 38 34.5 3 7.8
Multiparous 72 65.6 12 16.6
Table 7 Faecal incontinence assessed preoperatively related to 
the type of delivery
Childbirth Faecal 
incontinence
N° % N° %
C-section 27 24.5 3 11.1
Vaginal birth 45 40.5 9 20
Table 8 Faecal incontinence assessed preoperatively related to 
CAF’s location
Location of the CAF Patients Faecal 
incontinence
N° % N° %
Anterior 38 34.5 7 18.42
Posterior 72 65.6 8 11.1
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13% as well as a disfunction of EAS in the 59% of cases, 
while a disfunction of both sphincters arrives in the 
10% of cases. Richter et  al. [29] observed a sphincteric 
disfunction after vaginal delivery in the 35% of cases. 
Another risk factor recently took into account for the 
occurrence of CAF of the anterior commissure is the 
usage of water-jet stream in a bidet-toilet, which accord-
ing to Garg [30] strongly increase the incidence of this 
condition. Moreover, we conducted a review of the lit-
erature showing an incidence of CAF of the anterior 
commissure as high as 35.4% [31], this data owes its jus-
tification to the high number of multiparous women who 
gave birth by vaginal delivery along with the routine habit 
of using water-jet stream in a bidet toilet [30].
As for the differences in manometric parameters in 
various research, different authors [32–34] report that 
MSP values are significantly lower in female patients, as 
they represent the strength of the EAS, which is made by 
striated muscle. As a matter of fact, men have a greater 
striated muscle due to the well-known effect of testoster-
one of muscle growth [34]. MRP values, on the contrary, 
are similar in both sexes [32–35].
It appears logical to associate a chemical sphincterot-
omy for those patients who have hypertonic IAS, aiming 
to reduce the IAS tone and improve the IAS blood per-
fusion. We include various drugs fit for purpose, among 
these we considered Botulinum Toxin A and nifedipine. 
The first one has been injected during the surgery, there-
fore ensuring a high level of compliance; nevertheless, 
it is burdened by an augmented risk of FI, as we see in 
this study in one case, moreover, its employment in the 
treatment of CAF it is considered off label in Italy. On the 
other hand, nifedipine is employed by topical administra-
tion 15 days after surgery, therefore we experienced lower 
compliance as well as less side effects including FI. Both 
Nifedipine and Botulinum toxin A induce relaxation of 
the IAS tone with different mechanism. Botulinum toxin 
A reduces the release of noradrenaline at the neuromus-
cular junction of the peripheral nerves [36], inducing a 
constant relaxation of the smooth muscles without inter-
fering with the volunteer control of the continence [37]. 
The latter effect develops in few hours and the contrac-
tion start again within 3 or 4 months after the emergence 
of a new neuromuscular junction [37]. The nifedipine 
might be due also to its anti-inflammatory action not 
only to its induced reduction of the IAS tone [20, 38–
42], carried through the inhibition of calcium flow into 
the sarcoplasm of IAS. Experimental studies indicate 
that nifedipine has a modulating effect on microcircula-
tion [43], as well as a local anti-inflammatory effect [44]. 
Moreover, nifedipine might contribute to the healing 
process of CAF due to its additional free radical scaveng-
ing properties [45]. In our study we didn’t observe any 
adverse effects related to the employ of nifedipine such 
as headache or perianal dermatitis, patients’ compliance 
has been excellent. Available research focusing on LIS 
outcomes in female patients are few. Regadas et  al. [46] 
and Fernandes et  al. [47] analyzed respectively a series 
on 31 and 36 female patients affected by CAF hypertonic 
IAS, without FI or previous proctological procedure, 
who underwent LIS extended to the apex of the fis-
sure; they observed, in the 52–53% of cases. The authors 
highlighted, with a post-operative evaluation endoanal 
ultrasound (EAUS), that if LIS extension was greater 
than 20–25% of the IAS length (corresponding to less 
than 1 cm), the incidence of FI was significantly higher. 
It appears difficult, if not impossible, to divide exactly a 
quarter of the IAS length, as there is not any reference 
landmark neither with EAUS.
In their recent research Brillantino et  al. [48] per-
formed a sphincterotomy limited to the 20% of the IAS 
length as treatment for female patient affected by CAF 
with hypertonic IAS and without any clinical sign of FI, 
with the help of a new device introduced by themselves. 
This latter procedure requires a pre-operative evaluation 
with an EAUS and the researchers achieved very good 
results with a rate of healing of the 93.3% and a rate of 
recurrence of 6.2% without alteration of the anal conti-
nence. Nevertheless, this proctological surgery appears 
complex and requires equipment, which are not available 
in every hospital.
Even if a LIS limited to the 20% of the IAS length allows 
to achieve good results both in terms of healing and FI 
rate, in female patients affected by CAF with hypertonic 
IAS without signs of FI or previous proctological proce-
dure, this procedure appears difficult and requires further 
technical development. So that, up to date sphincter sav-
ing surgical procedure represent the treatment of choice 
for female patients affected by CAF regardless of the IAS 
tone, age, previous proctological procedure or presence 
of FI [49–53]. In fact, as for female patients a sphincter 
saving procedure appears mandatory given the higher 
risk of FI; these latter aim to perform a fissurectomy 
along with a wound debridement, removing the brady-
trophic scar tissue, producing a fresh wound edges and 
finally creating an acute fissure. The subsequent employ 
of a flap to cover up for the naked area is designed to 
relocate on this area healthy and fresh blood supplied tis-
sue, perfused by other arterial district [14].
Conclusion
The saving sphincter procedure we undertook, fis-
surectomy with V–Y advancement flap associated with 
chemical-pharmacological sphincterotomy for IAS tone 
reduction, in case of hypertonic IAS may represent an 
effective approach for the treatment of CAF in female 
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patients. Only in case of failure of these latter LIS could 
be taken into account as an alternative approach.
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